A study comparing effect of Steroid and Saline Nasal Packing in patients after Endoscopic Sinus Surgery.

Triamcinolone Nasal Packing in Functional Endoscopic Sinus Surgery: A Matched Pair Randomized Controlled Study. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099639

Enrollment

Registered

2025-12-22

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J329- Chronic sinusitis, unspecified

Interventions

Intervention1: Triamcinolone Acetonide: Dose: 40 mg Triamcinolone Acetonide per treated nasal cavity (0.5 ml of 40 mg/ml). Route: Topical intranasal via drug-impregnated nasal packing (Abgel and Polyv

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age more than 10 years. 2.Patient with bilateral chronic rhinosinusitis undergoing Functional endoscopic sinus surgery. 3.Patient willing to give informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients aged less than 10 years. 2.Patients with history of intolerance to Triamcinolone. 3.Patients with history of previous sinus surgery.

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of triamcinolone nasal packing in patients undergoing Functional endoscopic sinus surgery for chronic rhinosinusitis.Timepoint: 1st, 4th, 8th postoperative week.	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactTejaswini H

Sapthagiri Institute of Medical Science and Research Centre

dr.tejaswini81@gmail.com9986050155

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026